In the blink of an eye, twenty years have passed: in mid-October 2005, I joined Atlas Venture as a principal on the global life science team.  We closed Fund VII a few months after I joined; and, just...

We are delighted to launch our annual report, Equity Investment into University Spinouts 2025, in conjunction with Beauhurst.

Results are due soon from two studies using semaglutide to treat thousands of people with the disease

Small-molecule drug discovery has transitioned from traditional phenotypic screening to more precise target-based approaches, with an increased focus on understanding mechanisms of action (MoA) and ta...

This study shows that deep-learning-based co-folding models often produce physically unrealistic structures and are unsusceptible in their predictions to significant binding site modifications, demonstrating bias towards training data and underscoring the need for stronger integration of physical principles.